328 results about "Sex organ" patented technology

A medicament based on antibodies contains an activated form of ultra-low doses of monoclonal, polyclonal, or natural antibodies to the prostate-specific antigen, the activated form being prepared by multiple consecutive dilutions and exposure to external factors, preferably according to homeopathic technology. In order to obtain the antibodies, the prostate-specific antigen isolated from the prostatic tissues of cattle or prepared synthetically is employed; a mixture of various, mostly centesimal, homeopathic dilutions is used. The method of treating diseases of the urogenital sphere consists in using activated forms of ultra-low doses of antibodies to prostate-specific antigen prepared by multiple consecutive dilutions and exposure to external factors.

Therapeutic devices and methods according to embodiments of the invention alleviate e.g. urinary incontinence in female and male patients. Suction or vacuum, for example, is applied to the genital region, clitoris or clitoral region, the external urethral orifice, and / or other designated areas, e.g. physically stimulating the sacral / pudendal nerves and / or nerve roots and alleviating incontinence. Such embodiments also can encourage or cause clitoral engorgement, or otherwise promote blood flow in the genital region. Vacuum or suction applied to e.g. the clitoris creates a negative pressure in the clitoris that is lower than the systolic blood pressure, tending to promote engorgement of the clitoris with blood. Aspects of the invention are applicable not only to treatment of urinary and fecal incontinence, but also to the treatment of female sexual dysfunction. Aspects of the invention are also applicable to treatment of male incontinence and male erectile dysfunction.

Systems and methods treat urologic dysfunctions by implanting a lead and electrode in a tissue region affecting urologic function, and implanting a pulse generator in an anterior pelvic region remote from the electrode. Bilateral stimulation of the left and / or right branches of the dorsal genital nerves using a single lead implanted in adipose or other tissue in the region at or near the pubic symphysis is able to treat urinary incontinence.

Systems and methods treat urinary incontinence by the bilateral stimulation of the left and / or right branches of the dorsal genital nerves using a single lead implanted in adipose or other tissue in the region at or near the pubic symphysis.

A device and method for male impotence correction and female anorgasmy. An electronic stimulator with at least one pulse generator is implanted inside the body. At least one electrode is installed in the epidural space in the sacrum section of the spinal column and a conductor running under the user's skin electrically connects the electrode to the pulse generator. The stimulator is programmable and may be controlled from outside the body. Upon command initiated by the user or the user's lover the stimulator produces very short low-voltage electrical pulses in the sacrum section that are picked up by the nerves leading to the sex organs of the user, which stimulates arousal in the user's reproductive systems. The pulses are similar to the pulses generated by heart pacemakers. In other preferred embodiments the stimulator includes one or two drug chambers and a tube extending from each chamber to a nerve for producing stimulation of a sex organ. The present invention works on both males and females. In a preferred embodiment, the programmable electronic stimulator is implanted under the skin in the patient's back. Stimulation of the nerves coming out from the parasympathetic part of the spinal cord causes dilatation of the penile arteries in the male and in the clitoris arteries of the female, which results in an erection in the male and pre-orgasmic sensation in the female. In female, the stimulation of the sacral part of the spinal cord increases sexual desire and escalation to the level of orgasm. A preferred embodiment provides for emission stimulation. Emission is stimulated by electrical excitation of the sacral part of the spinal cord by increasing the voltage of the previous impulses. The device may be preprogrammed to set in motion the emission and ejaculation process at a predetermined time interval after the start of the erection process.

Therapeutic devices and methods according to embodiments of the invention alleviate e.g. urinary incontinence in female and male patients. Suction or vacuum, for example, is applied to the genital region, clitoris or clitoral region, the external urethral orifice, and / or other designated areas, e.g. physically stimulating the sacral / pudendal nerves and / or nerve roots and alleviating incontinence. Such embodiments also can encourage or cause clitoral engorgement, or otherwise promote blood flow in the genital region. Vacuum or suction applied to e.g. the clitoris creates a negative pressure in the clitoris that is lower than the systolic blood pressure, tending to promote engorgement of the clitoris with blood. Aspects of the invention are applicable not only to treatment of urinary and fecal incontinence, but also to the treatment of female sexual dysfunction. Aspects of the invention are also applicable to treatment of male incontinence and male erectile dysfunction.

An improved motorized decoy is provided for attracting and holding the attention of a live game animal by simulating the appearance, movements, sounds, and smells of a live game animal or an animal that is native to the habitat of a selected game animal. The decoy includes a decoy body that may be bifurcated into a forward portion and a rear portion, one or more motors, and an optional support member. Together, the motors may produce, either individually or in combination, the following movements: (1) movement of the entire decoy body relative to a fixed ground position, (2) movement of the head and neck portion of the decoy body relative to the rear portion of the decoy body, (3) movement of the ears relative to the head and neck portion, (4) movement of the tail relative to the rear portion, and (5) movement of one or more legs relative to the rear portion. All of the above movements may be produced randomly and / or intermittently by virtue of a programmable modulator or a multi-cycle remote control. All of the above movements may also be produced in sequential order by virtue of a multi-cycle remote control. Additional features include detachable antlers, detachable genitalia, and a scent disperser for distributing a chemical attractant. The invention also includes a method for attracting a game animal to a target area.

Devices for treatments of diseases and disorders associated with the gastrointestinal tract, especially the stomach, or urinogenital tract are described herein. Initially, the device is in a temporary form which is suitable for oral or rectal administration. After exposure to a stimulus, such as a temperature or pH change, the device changes shape to a permanent form, which allows it to become mechanically fixed in the stomach, esophagus or intestine. In one embodiment, the device is used to reduce the volume of the stomach, esophagus or intestine without interfering with the flow of the food through the gastrointestinal tract. The device may be used to help overweight patients lose weight and to deliver drugs to treat disorders and diseases in the in the stomach or intestine. The devices are manufactured from a stimuli-sensitive polymeric material, which is biocompatible and primarily adapted to the mechanical properties and geometry in the area to which it is applied. In the preferred embodiment, the material is a shape memory polymer. Depending on the desired application, the polymer may be either biodegradable or non-degradable.

A female stimulation device contained in a housing to deliver pulsating positive air pressure to the clitoris and other regions of the female genital region having an air pump / compressor, a length of tubing connected to the air pump / compressor, a variable control on the pump to increase or decrease the frequency of the pulsation, a regulator to vary the positive air pressure, a pressure gauge attached to the pump outlet and the regulator, a container connected to the compressor to provide a means to include a lubricant and / or scent in the air flow. Various tips to direct the pulsating positive air flow and direct mechanical stimulation to the clitoris and nearby regions are connectable to the tubing outlet.

The use of an inhibitor of a neuropeptide Y (NPY), preferably of a NPY Y1 receptor, which inhibitor is selective for an NPY or NPY Y1 receptor associated with male genitalia, in the preparation / manufacture of a medicament for the treatment or prevention of male erectile dysfunction (MED).

A unisex protective garment worn by both male and female animals, particularly dogs, the garment having a first forward harness portion and a rear genitalia protection portion. The rear portion includes a woven vinyl mesh material covering both the male genitalia and the female genitalia, in the same unisex garment, which would allow fluid flow, such as urine therethrough, but would prevent contact between male and female genitalia. This garment, when worn by either a male of female dog, would allow the dog to urinate and defecate, but would not allow the dog to copulate with the opposite sex.

This invention provides devices and methods for remodeling the female genital tissue, the device comprising a treatment tip, wherein the distal end of the treatment tip is conical, spherical, hemispherical, oval or circular in shape. The device further comprises one or more energy delivery elements for simultaneous cooling of the vaginal epithelium and transmission of energy for heating the tissues underneath the epithelium. In one embodiment, said device may further comprise one or more of the following: one or more temperature sensors for measuring the temperature at or below the epithelium; one or more directional sensors mounted on the hand piece or treatment tip; and one or more depth markers to show the depth of penetration of the treatment tip into the vagina. In another embodiment, this invention provides a device having a finger holder with electrodes for remodeling the female genital tissue.

This invention is a probiotic composition using the delivery mode of a rectal suppository for the treatment and relief of symptoms of urogenital infections including prostatitis. This invention is unique in both mode of delivery and in enabling the treatment of such urogenital infections as prostatitis. The present invention discloses compositions, methodologies, and delivery mode for the utilization of probiotic organisms in therapeutic compositions for treatment and relief from the symptoms of urogenital infections by maintaining and restoring normal flora in humans. The composition includes one or more bacteria selected from the genus Lactobacillus. More specifically, the invention relates to the utilization of one or more species or strains of Lactobacillus producing bacteria for the control of urinary tract bacteria and pathogens, including antibiotic-resistant urinary tract pathogens, and their associated diseases by both a reduction in the rate of colonization of the infection and pathogens. The method for treatment and relief from symptoms includes administration via a rectal suppository with a safe and effective amount of the composition. The delivery mode for administering the probiotic is via a rectal suppository. The delivery through the rectum provides an optimum method of transmission of the treatment.

This invention relates to a genital lubricant composition and to the uses thereof. The composition comprises i) fatty acids and / or homeopathic dilutions of plant extracts and ii) a physiologically acceptable carrier. According to a preferred embodiment, the genital lubricant composition comprises about 0.05% to about 0.5% hemp seed oil and a physiologically acceptable carrier so that it forms a lotion, a cream or a gel. The composition according to the invention is particularly useful for use as a vaginal moisturizer, or as a personal lubricant for use prior or during sexual intercourse.

A garment includes a bifurcated body having front and rear sections wherein the front section is provided with a sheath oriented about a genital region and includes a ribbed outer surface. The rear section is provided with a plurality of apertures and is oriented about a buttock region respectively. The ribbed outer surface includes a plurality of protrusions. The apparatus further includes a mechanism for fastening the garment about the user's waist. A condom is positionable about a user's penis wherein a proximal end portion of the condom is engageable about the ribbed outer surface of the sheath, defining a frictional contact area for assisting to maintain the condom positioned about the penis during sexual activities.

A male genital protection device configured to conform to the shape of the male genital anatomy, which provides the wearer with added comfort and protection.

Described herein are interactive devices that mimic a portion of a human male and a female genitalia. The male device includes a unique bead drive assembly for providing an extending and retracting motion. Also included on the male device is a massager sub-assembly able to inflate and deflate while being able to slide along a shaft of the male device. The female device includes a clamshell constrictor having an inflation mechanism that is able to provide a squeezing motion as well as being able to slide back and forth within the body of the female device. Also disclosed herein are method of communication and interaction between a pair of interactive devices or multiple interactive devices. Finally, methods of managing interactive sessions between multiple interactive devices are also described.

The present invention provides, in one embodiment, a method of normalizing the timing of sexual response in a mammal comprising the administration of an amount of a central nervous system sexual response initiator in an amount sufficient to produce genital vasodilation but less than the amount required to produce effective vasocongestive arousal. The method is applicable not only to adjusting or normalizing the timing of sexual response in humans, but in the breeding of valuable commercial animals such as horses, cattle, sheep, swine and the like and domesticated pets such as dogs and cats. In an alternative embodiment, the present invention provides a method for the prophylactic treatment of long-term tissue degradation in the genital organs comprising the administration to a mammal of a central nervous system sexual response initiator in an amount sufficient to produce genital vasodilation but less than the amount required to produce effective vasocongestive arousal. The preferred central nervous system sexual response initiator is apomorphine or a pharmaceutically acceptable acid addition salt thereof.

A driving apparatus of a massaging device for sexual organs comprises a pedestal, a driving device fixed detachably on the pedestal, and moving means provided on the driving device, to which a massaging device for sexual organs is attached. The moving means is moved reciprocally linearly, and vertically substantially, and the massaging device is for male sex organs. The moving means is moved reciprocally linearly, and obliquely substantially, and the massaging device is for female sex organs. A motion of lateral direction is added to the moving means so as to move the moving means along an endless loop.

The present invention relates to a pharmaceutical composition which may comprise progestogens, preferably drospirenone, estrogens, preferably ethinylestradiol and 5-methyl-(6S)-tetrahydrofolate, which may be employed as oral contraceptive and moreover prevents disorders caused by folate deficiency in the consumers, in particular cardiovascular disorders and, after conception of the embryo, congenital malformations caused by folate deficiency such as, for example, neural tube defects, ventricular valve defects, urogenital defects, and cleft lip, jaw and palate, without masking the symptoms of vitamin B12 deficiency, and at the same time even in the case of homozygous or heterozygous polymorphism of methylenetetrahydrofolate reductase facilitates unimpaired utilizability of the folate component 5-methyl-(6S)-tetrahydrofolate by the body and thus its biological activity for preventing the abovementioned congenital malformations caused by folate deficiency. In addition, a prolonged protective effect is maintained after discontinuation of the contraceptive.

According to the method of evaluating female genital cancer of the present invention, amino acid concentration data on concentration values of amino acids in blood collected from a subject to be evaluated is measured, and the state of female genital cancer including at least one of cervical cancer, endometrial cancer, and ovarian cancer in the subject is evaluated based on the concentration value of at least one of Thr, Ser, Asn, Gln, Pro, Gly, Ala, Cit, Val, Met, Ile, Leu, Tyr, Phe, His, Trp, Orn, Lys, and Arg contained in the measured amino acid concentration data of the subject.

The desensitizing device contains an electrical stimulation member optionally configured on a support member. The electrical stimulation member contains a control circuit, at least two electrodes, and an electricity supply element. The electricity supply element provides electricity to the control circuit, and the control circuit generates a stimulating current to the electrodes. By configuring a male genital with the support member so that the electrodes are in contact with the penis skin, the stimulating current produced by the control circuit is conducted to the electrodes and provides a low-strength subcutaneous nerve stimulation through the penis skin. The subcutaneous nerve is as such temporarily numbed and desensitized.

The present invention relates to a modular erogenous stimulation system including at least one vibratory device for stimulating the erogenous zones and at least one control module that for controlling the operation of the vibratory device; and to an embodiment of the at least one vibratory apparatus that may be worn by a female for stimulating the internal vaginal erogenous zones, the external clitoral erogenous zones, or both the internal and external clitoral erogenous zones of the female genitalia simultaneously, while allowing sufficient clearance of the vaginal canal to also permit insertion of a penis or other similarly configured and dimensioned implement, such as a dildo or vibrator, when the apparatus is being properly worn by the female to create an interaction between the partners that is pleasurable for all involved.

The present invention relates to an external urinary incontinence treatment a device and a method of deploying an external urinary incontinence treatment device that minimizes the inconvenience of fastening and fixating a urine receiving component to the genital region and to the skin surrounding the urethral orifice of a treated patient. The device comprises: a urine receiving component, a tube, a receiving component supporting element, a tube locking system, a genital region connection component, and a genital region anchoring element. The tube connects and communicates freely with the urine receiving component and is inserted through the receiving component supporting element. The tube also communicates with said tube locking system and is able to move vertically the receiving component supporting element when said tube locking system is deactivated. The tube is fixated in its movement at a desired position along the length of said tube when said tube locking system is activated. The device receiving component supporting element is connected to the genital region connection component and with the tube locking system. The genital region connection component is connected to the genital region anchoring element. In deployment of the device, the genital region anchoring element is reversibly connected to the skin of the genital region of the treated patient, and urine receiving-component is connected to the skin surrounding the urethral orifice of the treated patient when the tube is moved towards the genital region of the patient. The tube is reversibly fixated in place by the tube locking system after urine receiving component is adjusted and fastened to the skin surrounding the urethral orifice of the patient in a urine leak free connection while applying the minimal required pressure, thus, causing the treated patient minimal inconvenience. The tube lucking system can be easily deactivated and reactivated to adjust the connection of the receiving component to the skin surrounding the urethral orifice in accordance to changing body postures of the patient.